UTICA, N.Y., Feb. 21 /PRNewswire-FirstCall/ -- CONMED Corporation
(Nasdaq: CNMD) announced today that it will hold an Investment Community
Luncheon on Wednesday, February 23, 2005, at 12:00 p.m., Eastern Time, during
the American Academy of Orthopaedic Surgeons, which is being held in
Washington, DC.
Mr. Joseph J. Corasanti, President and Chief Operating Officer, will host
the meeting with presentations by management of the Company's Orthopaedic and
Endoscopic Technologies product groups.
A simultaneous webcast of the meeting will be accessible via the Company's
website at http://www.conmed.com. Replays will be made available through
March 2, 2005.
CONMED Profile
CONMED is a medical technology company with an emphasis on surgical
devices and equipment for minimally invasive procedures and monitoring. The
Company's products serve the clinical areas of arthroscopy, powered surgical
instruments, electrosurgery, cardiac monitoring disposables, endosurgery and
endoscopic technologies. They are used by surgeons and physicians in a
variety of specialties including orthopedics, general surgery, gynecology,
neurosurgery, and gastroenterology. Headquartered in Utica, New York, the
Company's 2,800 employees distribute its products worldwide from eleven
manufacturing locations.
Forward Looking Information
The presentation referenced by this press release may contain forward-
looking statements based on certain assumptions and contingencies that involve
risks and uncertainties. The forward-looking statements are made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform Act of
1995 and relate to the Company's performance on a going-forward basis. The
forward-looking statements involve risks and uncertainties which could cause
actual results, performance or trends, to differ materially from those
expressed in the forward-looking statements or in previous disclosures. The
Company believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management's
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct. In addition to general
industry and economic conditions, factors that could cause actual results to
differ materially from those discussed in the forward-looking statements
include, but are not limited to: (i) the failure of any one or more of the
Company's assumptions to prove to be correct; (ii) the risks relating to
forward-looking statements discussed in the Company's Annual Report on Form
10-K for the fiscal year ended December 31, 2003; (iii) cyclical purchasing
patterns from customers, end-users and dealers; (iv) timely release of new
products, and acceptance of such new products by the market; (v) the
introduction of new products by competitors and other competitive responses;
(vi) the possibility that any acquisition (and its integration) or other
transaction may require the Company to reconsider its financial assumptions
and goals/targets; and/or (vii) the Company's ability to devise and execute
strategies to respond to market conditions.
SOURCE CONMED Corporation
 back to top
Related links:
http://www.conmed.com
CONTACT:
Robert Shallish, Chief Financial Officer of
CONMED Corporation, +1-315-624-3206; or Investors, Julie Huang or
Lanie Marcus, or Media, Sean Leous, all of Financial Dynamics,
+1-212-850-5600, for CONMED Corporation
|
